Literature DB >> 12804393

Antibiotics for treating bacterial vaginosis in pregnancy.

H McDonald1, P Brocklehurst, J Parsons, R Vigneswaran.   

Abstract

BACKGROUND: Bacterial vaginosis is an imbalance of the normal vaginal flora with an overgrowth of anaerobic bacteria and a lack of the normal lactobacillary flora. Bacterial vaginosis during pregnancy has been associated with poor perinatal outcome and, in particular, preterm birth. Identification and treatment may reduce the risk of preterm birth and its consequences.
OBJECTIVES: To assess the effects of antibiotic treatment of bacterial vaginosis in pregnancy. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group trials register (September 2002). SELECTION CRITERIA: Randomized trials comparing antibiotic treatment with placebo or no treatment, or comparing two or more antibiotic regimens in pregnant women with bacterial vaginosis. DATA COLLECTION AND ANALYSIS: Two reviewers assessed trials and extracted data independently. Study authors were contacted for additional information. MAIN
RESULTS: Ten trials involving 4249 women were included; all were of good quality. Antibiotic therapy was effective at eradicating bacterial vaginosis during pregnancy (odds ratio (OR) 0.21, 95% confidence interval (CI) 0.18 to 0.24, eight trials of 3825 women). Treatment did not significantly reduce the risk of preterm birth before 37 weeks (OR 0.95, 95% CI 0.82 to 1.10, eight trials of 4062 women), 34 weeks (OR 1.20, 95% CI 0.69 to 2.07, five trials of 851 women), or 32 weeks (OR 1.08, 95% CI 0.70 to 1.68, three trials of 3080 women). However, antibiotic treatment did significantly decrease the risk of preterm prelabour rupture of membranes (OR 0.32, 95% CI 0.15 to 0.67, three trials of 562 women). In women with a previous preterm birth, treatment did not affect the risk of subsequent preterm birth (OR 0.83, 95% CI 0.59 to 1.17, five trials of 622 women) but it did decrease the risk of preterm prelabour rupture of membranes (OR 0.14, 95% CI 0.05 to 0.38, two trials of 114 women) and low birthweight (OR 0.31, 95% CI 0.13 to 0.75, five trials of 622 women). REVIEWER'S
CONCLUSIONS: Antibiotic treatment can eradicate bacterial vaginosis in pregnancy. However, the current evidence does not support screening and treating all pregnant women with asymptomatic bacterial vaginosis to prevent preterm birth and its consequences. For women with a previous preterm birth, there is little suggestion that detection and treatment of bacterial vaginosis will prevent a further preterm birth, but it may reduce the risk of low birthweight and preterm prelabour rupture of membranes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804393     DOI: 10.1002/14651858.CD000262

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  8 in total

1.  Does screening reduce preterm births?

Authors:  Anna Alanen
Journal:  BMJ       Date:  2004-08-14

Review 2.  Bacterial vaginosis: more questions than answers.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 3.  Obstetric issues in preterm birth.

Authors:  Deirdre J Murphy; Peter W Fowlie; William McGuire
Journal:  BMJ       Date:  2004-10-02

Review 4.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 5.  The management of preterm labour.

Authors:  Jayanta Chatterjee; Joanna Gullam; Manu Vatish; Steve Thornton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03       Impact factor: 5.747

Review 6.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

7.  Vaginal Immunity in Bacterial Vaginosis.

Authors:  Sabina Cauci
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

8.  Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women.

Authors:  Brenna L Anderson; Susan Cu-Uvin; Christina A Raker; Christine Fitzsimmons; Sharon L Hillier
Journal:  Acta Obstet Gynecol Scand       Date:  2011-03-14       Impact factor: 3.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.